Companies law tweak set to cost pharma firms millions

Drug companies have warned government over having to apply for regulatory approval in more than 200 jurisdictions

30th April, 2017
Minister for Enterprise Mary Mitchell O’Connor

A small change in Irish company law could end up costing pharmaceutical companies €25 million.

Drug companies have been warning the government that the requirement for them to state their official corporate name in all documents will result in them having to apply for regulatory approval in more than 200 jurisdictions.

As part of an updating of Irish company law, firms must state whether they are ‘limited’, ‘unlimited’, ‘Plc’ or ‘DAC’ at the end of their...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Potential use of rapid antigen tests in workplaces and schools to be assessed

‘The next few weeks will give us hope if we can hang in there’

Health Danielle Barron 5 days ago

Lifting of ban on visits to nursing homes now urged

Health Danielle Barron 5 days ago